VLVbio is a Swedish biotechnology company located in Nacka, Stockholm and was established in 2013. We manufacture, R&D, and sell the PEVIVA products. Better tools for more accurate detection of liver damage - that is VLVbio's mission. That is why we present our M30 and M65 ELISA assays, measuring apoptosis and total cell death by quantification of caspase-cleaved and total keratin 18, respectively. That is why we are aiming at setting new industry standards for the identification of liver injury and tumor control. Our products are CE-marked and are used in the fields of hepatology, oncology, and toxicology. The dead cells still count!
| Website | http://www.vlvbio.com |
| Revenue | $1 million |
| Employees | 8 (5 on RocketReach) |
| Founded | 2013 |
| Address | 32 Hästholmsvägen, Nacka, Stockholm 13130, SE |
| Phone | +46 8 122 053 00 |
| Technologies |
JavaScript
,
HTML
,
PHP
+8 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Business Services |
| Competitors | The Janssen Pharmaceutical Companies of Johnson & Johnson, Pfizer, Sanofi, GSK, Moderna Therapeutics, Novavax, CureVac, INOVIO Pharmaceuticals, Inc., Medicago, Vaxine Pty Ltd +35 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular VLVbio employee's phone or email?
The VLVbio annual revenue was $1 million in 2026.
Slavica Brnjic is the Verkställande direktör of VLVbio.
5 people are employed at VLVbio.
VLVbio is based in Nacka, Stockholm.
The NAICS codes for VLVbio are [54171, 54, 541713, 541, 5417].
The SIC codes for VLVbio are [87, 873].